TY - JOUR
T1 - Assessing associations between the AURKA-HMMR-TPX2-TUBG1 functional module and breast cancer risk in BRCA1/2 mutation carriers
AU - Blanco, Ignacio
AU - Kuchenbaecker, Karoline
AU - Cuadras, Daniel
AU - Wang, Xianshu
AU - Barrowdale, Daniel
AU - de Garibay, Gorka Ruiz
AU - Librado, Pablo
AU - Sánchez-Gracia, Alejandro
AU - Rozas, Julio
AU - Bonifaci, Núria
AU - McGuffog, Lesley
AU - Pankratz, Vernon S
AU - Islam, Abul
AU - Mateo, Francesca
AU - Berenguer, Antoni
AU - Petit, Anna
AU - Català, Isabel
AU - Brunet, Joan
AU - Feliubadaló, Lidia
AU - Tornero, Eva
AU - Benítez, Javier
AU - Osorio, Ana
AU - Ramón y Cajal, Teresa
AU - Nevanlinna, Heli
AU - Aittomäki, Kristiina
AU - Arun, Banu K
AU - Toland, Amanda E
AU - Karlan, Beth Y
AU - Walsh, Christine
AU - Lester, Jenny
AU - Greene, Mark H
AU - Mai, Phuong L
AU - Nussbaum, Robert L
AU - Andrulis, Irene L
AU - Domchek, Susan M
AU - Nathanson, Katherine L
AU - Rebbeck, Timothy R
AU - Barkardottir, Rosa B
AU - Jakubowska, Anna
AU - Lubinski, Jan
AU - Durda, Katarzyna
AU - Jaworska-Bieniek, Katarzyna
AU - Claes, Kathleen
AU - Van Maerken, Tom
AU - Díez, Orland
AU - Hansen, Thomas V
AU - Jønson, Lars
AU - Gerdes, Anne-Marie
AU - Ejlertsen, Bent
AU - de la Hoya, Miguel
AU - Teixeira
PY - 2015/4/1
Y1 - 2015/4/1
N2 - While interplay between BRCA1 and AURKA-RHAMM-TPX2-TUBG1 regulates mammary epithelial polarization, common genetic variation in HMMR (gene product RHAMM) may be associated with risk of breast cancer in BRCA1 mutation carriers. Following on these observations, we further assessed the link between the AURKA-HMMR-TPX2-TUBG1 functional module and risk of breast cancer in BRCA1 or BRCA2 mutation carriers. Forty-one single nucleotide polymorphisms (SNPs) were genotyped in 15,252 BRCA1 and 8,211 BRCA2 mutation carriers and subsequently analyzed using a retrospective likelihood approach. The association of HMMR rs299290 with breast cancer risk in BRCA1 mutation carriers was confirmed: per-allele hazard ratio (HR) = 1.10, 95% confidence interval (CI) 1.04 - 1.15, p = 1.9 × 10-4 (false discovery rate (FDR)-adjusted p = 0.043). Variation in CSTF1, located next to AURKA, was also found to be associated with breast cancer risk in BRCA2 mutation carriers: rs2426618 per-allele HR = 1.10, 95% CI 1.03 - 1.16, p = 0.005 (FDR-adjusted p = 0.045). Assessment of pairwise interactions provided suggestions (FDR-adjusted pinteraction values > 0.05) for deviations from the multiplicative model for rs299290 and CSTF1 rs6064391, and rs299290 and TUBG1 rs11649877 in both BRCA1 and BRCA2 mutation carriers. Following these suggestions, the expression of HMMR and AURKA or TUBG1 in sporadic breast tumors was found to potentially interact, influencing patients' survival. Together, the results of this study support the hypothesis of a causative link between altered function of AURKA-HMMR-TPX2-TUBG1 and breast carcinogenesis in BRCA1/2 mutation carriers.
AB - While interplay between BRCA1 and AURKA-RHAMM-TPX2-TUBG1 regulates mammary epithelial polarization, common genetic variation in HMMR (gene product RHAMM) may be associated with risk of breast cancer in BRCA1 mutation carriers. Following on these observations, we further assessed the link between the AURKA-HMMR-TPX2-TUBG1 functional module and risk of breast cancer in BRCA1 or BRCA2 mutation carriers. Forty-one single nucleotide polymorphisms (SNPs) were genotyped in 15,252 BRCA1 and 8,211 BRCA2 mutation carriers and subsequently analyzed using a retrospective likelihood approach. The association of HMMR rs299290 with breast cancer risk in BRCA1 mutation carriers was confirmed: per-allele hazard ratio (HR) = 1.10, 95% confidence interval (CI) 1.04 - 1.15, p = 1.9 × 10-4 (false discovery rate (FDR)-adjusted p = 0.043). Variation in CSTF1, located next to AURKA, was also found to be associated with breast cancer risk in BRCA2 mutation carriers: rs2426618 per-allele HR = 1.10, 95% CI 1.03 - 1.16, p = 0.005 (FDR-adjusted p = 0.045). Assessment of pairwise interactions provided suggestions (FDR-adjusted pinteraction values > 0.05) for deviations from the multiplicative model for rs299290 and CSTF1 rs6064391, and rs299290 and TUBG1 rs11649877 in both BRCA1 and BRCA2 mutation carriers. Following these suggestions, the expression of HMMR and AURKA or TUBG1 in sporadic breast tumors was found to potentially interact, influencing patients' survival. Together, the results of this study support the hypothesis of a causative link between altered function of AURKA-HMMR-TPX2-TUBG1 and breast carcinogenesis in BRCA1/2 mutation carriers.
KW - Antigens, CD44
KW - Aurora Kinase A
KW - Breast Neoplasms
KW - Carcinogenesis
KW - Cell Cycle Proteins
KW - Estrogen Receptor alpha
KW - Evolution, Molecular
KW - Extracellular Matrix Proteins
KW - Female
KW - Genes, BRCA1
KW - Genes, BRCA2
KW - Genetic Loci
KW - Genetic Predisposition to Disease
KW - Humans
KW - Likelihood Functions
KW - Mammary Glands, Human
KW - Microtubule-Associated Proteins
KW - Mutation
KW - Nuclear Proteins
KW - Polymorphism, Single Nucleotide
KW - Retrospective Studies
KW - Tubulin
U2 - 10.1371/journal.pone.0120020
DO - 10.1371/journal.pone.0120020
M3 - Journal article
C2 - 25830658
SN - 1932-6203
VL - 10
SP - 1
EP - 18
JO - P L o S One
JF - P L o S One
IS - 4
M1 - e0120020
ER -